Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis.
Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis.
Systematic network lesioning reveals the core white matter scaffold of the human brain.
Cardiac Sympathetic Hyperactivity in a Patient with Guillain-Barré Syndrome: An Analysis Using Cardiac [(123)I] Metaiodobenzylguanidine (MIBG) Scintigraphy.
Socio-economic factors and immigrant population studies of multiple sclerosis.
The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.
Human mesenchymal stem cells target adhesion molecules and receptors involved in T cell extravasation.
Functional course of Progressive Multifocal Leukoencephalopathy.
Homeostasis of Microglia in the Adult Brain: Review of Novel Microglia Depletion Systems.
Vitamin D Modulates the Expression of IL-27 and IL-33 in the Central Nervous System in Experimental Autoimmune Encephalomyelitis (EAE).
Evidence of Oxidative Stress in Very Long Chain Fatty Acid - Treated Oligodendrocytes and Potentialization of Ros Production Using Rna Interference Directed Knockdown of Abcd1 and Acox1 Peroxisomal Proteins.
Interferon-β Induces Hepatocyte Growth Factor in Monocytes of Multiple Sclerosis Patients.
Prognostic indicators of secondary progression in a paediatric-onset multiple sclerosis cohort in Kuwait.
SPG5 and multiple sclerosis: clinical and genetic overlap?
The clinical features and diagnosis of Metachromatic leukodystrophy: A case series of Iranian Pediatric Patients.
Identifying clues to molecular etiology of multiple sclerosis in South Indian patients.
NFATc1 deficiency in T cells protects mice from experimental autoimmune encephalomyelitis.
Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis.
Specific immune complexes augment in vitro acetylcholine receptor-specific T-cell proliferation.
Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
Natalizumab discontinuation in the increasing complexity of multiple sclerosis therapy.
Quetiapine mitigates the neuroinflammation and oligodendrocyte loss in the brain of C57BL/6 mouse following cuprizone exposure for one week.
Novel Insights and Therapeutics in Multiple Sclerosis.
Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders.
Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis.

Pages